Table 2.
Median time till viral clearance.
N (184) | Hazards of viral clearancea [HR (95% CI)] | Time till viral clearance [median (IQR)] | p-value—log rank test | |
---|---|---|---|---|
Sex | ||||
Males | 69 | 1.1 (0.7–1.5) | 11 (8–14) | 0.622 |
Females | 115 | Reference group | 12 (10–14) | |
Age group | ||||
0–29 | 25 | Reference group | 11 (8–13) | 0.265 |
30–39 | 23 | 0.7 (0.4–1.3) | 11 (8–13) | |
40–49 | 39 | 0.8 (0.5–1.4) | 11 (8–13) | |
50–59 | 56 | 0.7 (0.4–1.2) | 12 (9–14.5) | |
60+ | 41 | 0.6 (0.4–1.0) | 13 (9–14) | |
Symptoms | ||||
Asymptomatic | 145 | Reference group | 11 (8–14) | 0.491 |
Symptomatic | 39 | 1.08 (0.7–1.5) | 11 (9–14) |
Adjusted for all predictor variables.